Imunoterapi dengan Keytruda (Pembrolizumab) Dokter Terbaik di Telavive - TOP-15 dokter

• Dr. Ofer Merimsky mengkhususkan diri dalam imunoterapi dengan keytruda (pembrolizumab) untuk pasien kanker paru-paru.
• Berlatih dalam bidang radioterapi dan brakiterapi di New York Hospital, Amerika Serikat.
• Anggota dari American Scientific Cancer Society dan European Society of Oncology.
• Tersertifikasi oleh Israeli Society for Oncology and Radiotherapy.
• Anggota aktif dari American Society of Clinical Oncology (ASCO), Amerika Serikat.

• Dr. Pelles Sharon mengkhususkan diri dalam imunoterapi dengan keytruda (pembrolizumab) untuk pengobatan kanker.
• Menggunakan pengujian biomarker yang tepat untuk menyesuaikan terapi keytruda (pembrolizumab) bagi pasien individu.
• Menerima pelatihan lanjutan dalam imunoterapi di AS dan Jerman.
• Bersertifikat oleh American Board of Oncology dan anggota European Society for Medical Oncology.
• Fasih berbahasa Inggris, Jerman, dan Ibrani.

• Dr. David Sarid berspesialisasi dalam imunoterapi dengan pembrolizumab untuk berbagai jenis kanker.
• Beliau menjalani pelatihan di Israel, Inggris, dan Georgia, yang memperluas perspektif medisnya.
• Beliau adalah anggota dari European Society for Medical Oncology dan American Society of Clinical Oncology.
• Beliau telah menulis lebih dari 30 artikel tentang pengobatan kanker, berkontribusi pada penelitian medis.
• Beliau adalah dosen di Tel Aviv University, tempat ia membagikan pengetahuannya tentang terapi kanker.

Dr. K.K. Iswaran is a highly experienced Obstetrician and Gynaecologist with 25+ years of experience in Obstetrics & Gynaecology Reproduction Medicine, IUI - Intrauterine Insemination, Ovulation Induction Procedure, Ovarian Drilling (Multiperforation), Urethral Valves, and more. He holds a Fellowship, Diploma, and MBBS from the Ronald O Perelman and Claudia Cohen Centre, Ireland, and the University of Mysore, India respectively.

Dr. Ronit El Hasid is the Head of Pediatric Oncohematology and Oncology at Dana Dwek Children’s Hospital (Sourasky). She specializes in bone marrow and umbilical blood transplantation and has conducted over 300 transplantations and published 50 papers and 40 reports. She is a member of American Association for Hematology and Israeli Society for Pediatric Hematooncology, and has previously practiced in the City of Hope Hospital (Los-Angeles) and other medical centers in Israel.

Dr. Ron Ram is board-certified in Internal Medicine, Hematology, and Medical Oncology. He completed his residency at the State University of New York at Brooklyn. He also finished a fellowship in Hematology and Oncology at New York Medical College, Westchester Medical Center.

Dr. Ram has performed several hundred stem cell transplants. This shows his strong expertise in the field. He has published over 30 articles in peer-reviewed journals. He has also contributed a chapter to a medical textbook. These achievements reflect his commitment to research and education.

Dr. Ido Wolf adalah seorang spesialis dalam Onkologi, Ilmu Penyakit Dalam, dan Unit Kesehatan Militer dengan gelar dari Universitas Ben Gurion di Negev. Saat ini, beliau menjabat sebagai Kepala Divisi Onkologi Medis di Sourasky Medical Center dan berbicara bahasa Inggris.

Profesor Ari Rafael — direktur layanan Onkologi Translasional dan peneliti di departemen penelitian klinis kanker di Pusat Medis Suraski (Ichilov, Tel Aviv). Pasien menghargai pendekatannya yang individual dan perhatian terhadap kebutuhan setiap individu.

Kualifikasi dan nilai bagi pasien:

• Memimpin rumah sakit onkologi siang hari dan mengarahkan proyek-proyek kedokteran genom nasional. Hal ini memastikan akses ke penelitian terkini.

• Bekerja sebagai penyelidik sub-utama dan penyelidik utama dalam banyak uji klinis fase I–III, termasuk suntikan intratumoral mRNA dan obat-obatan virus. Pasien mendapatkan kesempatan untuk berpartisipasi dalam metode pengobatan inovatif.

• Memiliki pengalaman internasional di AS dan Inggris — menjamin penerapan standar dunia dan protokol canggih.

• Anggota organisasi internasional (ESMO, IASLC, ISLB, ISCORT, Asosiasi Medis Israel). Menggunakan standar pengobatan modern dan berpartisipasi dalam penelitian global.

• Secara rutin meningkatkan kualifikasi dan mengikuti pelatihan sesuai standar praktik klinis internasional, termasuk ICH GCP R2, Panduan MOH Israel, serta kursus terbaru tentang persetujuan yang diinformasikan, penanganan efek samping, dan keselamatan pasien.

Pasien menghargai Profesor Rafael atas pilihan rencana pengobatan yang tepat, penerapan inovasi, dan perhatian yang mendetail, yang memberikan rasa percaya dan aman pada setiap tahap terapi.

Dr. Dror Levin is a senior pediatrician and director of the blood disorder and bone cancer (sarcoma) treatment departments at Children's Hospital "Dana" and Medical Center "Sourasky" respectively. He is a specialist in pediatric medicine, hematology, and oncology, with additional experience studying abroad at the Rizzoli Orthopaedic Institute in Italy.

Dr. Irina Stepfansky is an oncologist and internal medicine specialist at Sourasky Medical Center. She has more than 25 years of clinical experience. Since 2015, she has directed the Oncology Hospitalization department. Dr. Stepfansky earned her medical degree from Grodno University in Belarus. She completed advanced oncology training at Tel Aviv Medical Center.

Dr. Stepfansky has been licensed in Israel since 2000. She has led and participated in many phase I-III oncology clinical trials. Her work has helped improve cancer care and patient outcomes. She is recognized for her expertise in both internal medicine and oncology. Dr. Stepfansky has a strong record in research and clinical leadership.

Dr. Herishanu Yair is a hematologist with 25 years of experience. He specializes in chronic lymphocytic leukemia (CLL). He is skilled in bone marrow transplantation, immunotherapy, CAR T-cell therapy, and leukemia chemotherapy.

Dr. Herishanu has received several awards, including the Young Investigator Research Prize, Clinical Excellence Prize, and Klitzberg Oncology Award. He has made important contributions to CLL research. His work includes many published studies and research grants from leading institutions.

He is a member of the Israeli and American Hematology Associations. This highlights his expertise and dedication to the field of hematology.

Chief Physician of the Oncology Center, Oncologist